Capitolis Liquid Global Markets Llc

Source: SEC Form 13F · as of Mar 2026

Capitolis Liquid Global Markets Llc holds 28 biotech & pharma companies tracked by BioSniper, totaling $1.25B in value as of Mar 2026 (SEC Form 13F).

Companies held

28

Total value held

$1.25B

CompanySharesValue
LLYELI LILLY & Co368,169$338.6M
ABBVAbbVie Inc.673,444$146.5M
JNJJOHNSON & JOHNSON567,301$138.7M
TERNTerns Pharmaceuticals, Inc.1,975,800$104.2M
GILDGILEAD SCIENCES, INC.642,000$89.5M
UNHUnitedHealth Group Incorporated Common Stock (DE)276,830$74.9M
REGNREGENERON PHARMACEUTICALS, INC.75,000$57.9M
GPCRStructure Therapeutics Inc.1,151,300$55.5M
APLSApellis Pharmaceuticals, Inc.1,013,500$40.8M
MRKMerck & Co., Inc.223,830$26.9M
VTRSViatris Inc1,901,000$25.7M
ROIVRoivant Sciences Ltd.725,000$20.1M
ELVElevance Health Inc.65,038$19.0M
PMPhilip Morris International Inc92,410$15.3M
ARQTArcutis Biotherapeutics, Inc.500,000$11.8M
ABTABBOTT LABORATORIES108,011$11.1M
MCKMcKesson Corporation11,183$9.7M
INBXInhibrx Biosciences, Inc.125,000$8.4M
MOHMolina Healthcare Inc61,000$8.1M
VRTXVERTEX PHARMACEUTICALS INC / MA16,806$7.5M
IDXXIDEXX LABORATORIES INC /DE13,147$7.4M
ZTSZoetis Inc.62,000$7.3M
PFEPFIZER INC248,971$7.0M
BMYBRISTOL MYERS SQUIBB CO100,000$6.1M
CORCencora Inc.18,200$5.7M
JAZZJazz Pharmaceuticals plc28,000$5.3M
AMGNAMGEN INC13,775$4.8M
CAHCardinal Health Inc.5,700$1.2M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Capitolis Liquid Global Markets Llc — Biotech 13F Holdings & Portfolio | BioSniper